Showing results (671-680 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|December 20, 2002
Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?Giuseppe Maina, Umberto Albert, Simona Ziero, et al.International Clinical Psychopharmacology|December 20, 2002
Mirtazapine in the treatment of panic disorder: an open-label trialM Sarchiapone, M Amore, S De Risio, et al.International Clinical Psychopharmacology|October 9, 2002
Clinical utility of milnacipran in comparison with other antidepressantsJean-Claude BisserbeInternational Clinical Psychopharmacology|December 1, 1996
Severe withdrawal akathisia following neuroleptic discontinuation successfully controlled by clozapineM Poyurovsky, H Hermesh, A WeizmanInternational Clinical Psychopharmacology|December 1, 1996
New developments in obsessive-compulsive disorder research: implications for clinical managementY Sasson, J ZoharInternational Clinical Psychopharmacology|December 1, 1996
Obsessive-compulsive disorder-related disorders: the role of selective serotonergic reuptake inhibitorsE HollanderInternational Clinical Psychopharmacology|September 1, 1995
Neurocircuitries and neurotransmitter interactions in schizophreniaA CarlssonInternational Clinical Psychopharmacology|September 1, 1995
Aetiology of schizophrenia: an evolutionary theoryT J CrowInternational Clinical Psychopharmacology|September 1, 1995
The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptomsH J MöllerInternational Clinical Psychopharmacology|September 1, 1995
Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in manS Nyberg, A L Nordström, C Halldin, et al.Pageof 212